The Priority Review

Tag

Alectinib

1 story

  1. Clinical trials

    Hoffmann-La Roche posts results of Phase 3 alectinib rollover study

    Results for the study were first posted on ClinicalTrials.gov on October 9, 2026. The completed Phase 3 rollover study enrolled 50 participants and compared alectinib with crizotinib in patients with ALK- or RET-positive cancer.